Rayont Ownership

RAYT Stock  USD 0.03  0.00  0.00%   
Rayont owns a total of 50.16 Million outstanding shares. Rayont has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Rayont in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Rayont, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rayont Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Rayont Pink Sheet Ownership Analysis

About 52.0% of the company outstanding shares are owned by corporate insiders. The book value of Rayont was at this time reported as 0.13. The company last dividend was issued on the 21st of May 2018. Rayont Inc had 1:20 split on the 21st of May 2018. Rayont Inc., through its subsidiary, THF Holdings Pty Ltd., operates as a cancer treatment and medical device company. Rayont Inc. was founded in 2011 and is based in Southport, Australia. RAYONT INC operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 3 people.The quote for Rayont Inc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Rayont Inc contact Marshini Moodley at 61 4 3205 1512 or learn more at https://rayont.com.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Rayont Pink Sheet Analysis

When running Rayont's price analysis, check to measure Rayont's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rayont is operating at the current time. Most of Rayont's value examination focuses on studying past and present price action to predict the probability of Rayont's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rayont's price. Additionally, you may evaluate how the addition of Rayont to your portfolios can decrease your overall portfolio volatility.